These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27539362)

  • 1. Reappraising the timing of transplant for indolent non-Hodgkin lymphomas.
    Capria S; Barberi W; Perrone S; Ferretti A; Salaroli A; Annechini G; D'Elia GM; Foà R; Pulsoni A
    Expert Rev Hematol; 2016 Oct; 9(10):951-64. PubMed ID: 27539362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the role of autologous transplant for lymphoma in the current era?
    Stiff P
    Hematology Am Soc Hematol Educ Program; 2015; 2015():74-81. PubMed ID: 26637704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
    Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
    Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
    Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
    Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.
    Bhatt VR; Vose JM
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.
    Picleanu AM; Novelli S; Monter A; Garcia-Cadenas I; Caballero AC; Martino R; Esquirol A; Briones J; Sierra J
    Ann Hematol; 2017 May; 96(5):787-796. PubMed ID: 28168350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma.
    Bhatt VR; Armitage JO
    Expert Opin Biol Ther; 2016; 16(1):57-66. PubMed ID: 26515478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
    Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
    Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response.
    Gisselbrecht C; Vose J; Nademanee A; Gianni AM; Nagler A
    Oncologist; 2009; 14 Suppl 2():41-51. PubMed ID: 19819923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
    Holmberg LA; Stewart FM
    Oncology (Williston Park); 2003 May; 17(5):627-32, 635, 640; discussion 640-2. PubMed ID: 12800792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.
    Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.
    William BM; Allen MS; Loberiza FR; Bociek RG; Bierman PJ; Armitage JO; Vose JM
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):536-42. PubMed ID: 24434781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant?
    Hamadani M
    Bone Marrow Transplant; 2013 Aug; 48(8):1013-21. PubMed ID: 23000653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma.
    Morris EC; Mackinnon S
    Best Pract Res Clin Haematol; 2005 Mar; 18(1):129-42. PubMed ID: 15694189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma.
    Bhatt VR
    Curr Hematol Malig Rep; 2016 Jun; 11(3):196-207. PubMed ID: 26983957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional allograft and autograft in low grade lymphoma.
    Avivi I; Goldstone AH
    Best Pract Res Clin Haematol; 2005 Mar; 18(1):113-28. PubMed ID: 15694188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial.
    Glass B; Hasenkamp J; Wulf G; Dreger P; Pfreundschuh M; Gramatzki M; Silling G; Wilhelm C; Zeis M; Görlitz A; Pfeiffer S; Hilgers R; Truemper L; Schmitz N;
    Lancet Oncol; 2014 Jun; 15(7):757-66. PubMed ID: 24827808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous and allogeneic transplantation for aggressive NHL.
    Smith SM; Grinblatt D; van Besien K
    Cytotherapy; 2002; 4(3):223-40. PubMed ID: 12194719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
    Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.
    Robinson S; Dreger P; Caballero D; Corradini P; Geisler C; Ghielmini M; Le Gouill S; Kimby E; Rule S; Vitolo U; Dreyling M; Hermine O;
    Leukemia; 2015 Feb; 29(2):464-73. PubMed ID: 25034148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.